Bruntwood SciTech has named Chris Oglesby as its CEO as it enters a new stage of growth.
That growth is the recently announced £500m investment into the business.
Oglesby, currently its Executive Chair will replace joint CEO and CFO Kate Lawlor, who’s “decided that she would like to take on a new challenge.”
“As we enter into the next phase of Bruntwood SciTech’s growth we continue to set ourselves ambitious targets. By 2032, we plan to create a £5 billion UK-wide portfolio that can support 2,600 high-growth companies spanning life sciences, technology, and broader innovation, and I am confident that the strength of the people we have within the business will get us there,” said Oglesby.
“I want to take this opportunity to thank Kate for all she’s done for the business. I am particularly grateful to Kate for her instrumental role in leading Bruntwood SciTech over the past five years, as CFO initially and then joint CEO and CFO, and culminating in her outstanding contribution to bring a third investor and new partner into the company. Her passion, perseverance and dedication to succeed over the past 12 years,.
“She leaves with our gratitude and the very best wishes from me, the business, and her colleagues.”
Kevin Crotty will take on the role of Chief Financial Officer.
The £500m funding came through the Greater Manchester Pension Fund (£150m) and a “significant increase” in investment from existing shareholders, Legal & General and Bruntwood.
